期刊文献+

用HPLC法测定头孢丙烯的血浆浓度并应用于健康人体药动学研究 被引量:2

Determination of plasma concentrations of cefprozil by HPLC method and its application to pharmacokinetic study in healthy volunteers
下载PDF
导出
摘要 目的:建立测定人血浆中头孢丙烯浓度的HPLC法,并应用于健康人体药动学研究。方法:10名男性健康志愿者单剂量口服500mg头孢丙烯片,以HPLC法测定血浆中头孢丙烯浓度,采用非房室模型法计算药动学参数。结果:主要的药动学参数如下:cmax(8.64±1.00)μg/mL,tmax(2.00±0.85)h,t1/2(1.47±0.27)h,MRT(2.88±0.49)h,C1/F(17.964±2.50)L/h,AUC0~10(28.05±4.60)μg·h·mL^-1和AUC0-∞(2842±4.75)μg·h·mL^-1结论:本方法的准确度、灵敏度、专属性及重现性等符合生物样品的分析要求,适用于头孢丙烯片的人体药动学研究。 Objective: To establish a HPLC method to determine the plasma concentrations of cefprozil and study its pharmacokinetics in healthy volunteers. Methods: Ten male healthy volunteers received a single oral dose of 500 mg of cefprozil tablets. The plasma concentrations of cefprozil were determined by HPLC method. The pharmacokinetic parameters were calculated by non-compartment model. Results: The main pharmacokinetic parameters of cefprozil were cmax (8.64±1.00) μg/mL, tmax(2.00±0.85) h,t12 (1.47±0.27) h,MRT(2, 88±0.49) h,C1/F (17.96±2.50) L/h,AUC0-10 (28.05±4.60) μg· h · mL^-1 and AUC0-∞ (28.42±4.75) μg· h · mL^-1. Conclusion:This method is proved to be accurate, sensitive, specific and reproducible for the determination of cefprozil in human plasma. It is suitable for pharmacokinetic study of cefprozil tablets in healthy volunteers.
出处 《药学服务与研究》 CAS CSCD 2008年第1期46-48,共3页 Pharmaceutical Care and Research
关键词 头孢丙烯 色谱法 高压液相 药代动力学 cefprozil chromatography, high pressure liquid pharmacokinetics
  • 相关文献

参考文献7

二级参考文献34

  • 1张明发.头孢丙烯的抗菌药理与临床[J].上海医药,2005,26(3):111-117. 被引量:33
  • 2雷招宝.新的口服头孢菌素——头孢普齐[J].中国新药杂志,1994,3(5):24-26. 被引量:3
  • 3Park TH, Kim JK, Jee JP, Park JS, Kim CK. HPLC method for simultaneous determination of cefprozil diastereomers in human plasma[J]. J Pharm Biomed Anal, 2004,36: 243 - 8. 被引量:1
  • 4[1]Hoshi H, Okumura J. Substituted vinyl cephalosporins [P]. US:4520022, 1985-05-28; DE: 3402642, 1984-08-02. (CA 1984,101: 191542) 被引量:1
  • 5[2]Naito T, Hoshi H, Aburaki S, et al. Synthesis and structureactivity relationships of a new oral cephalosporin, BMY-28100and related compounds [J]. J Antibiot (Tokyo), 1987, 40 (7):991-1005. 被引量:1
  • 6[3]Alan GL, Greenford NGW. Preparation of 4-carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group [P]. US:3769277, 1973-10-30. (CA 1975, 82: 125043) 被引量:1
  • 7[4]Niall GW. 3-Vinyl-7- (2,2-disubstituteb acetamino) -cephalosporins. [P] US: 3994884, 1976 (CA 1971, 75:118328) 被引量:1
  • 8[5]Shiozaki M, Ishida N, Iino K, et al. Cleavage and some modifications of the 7-amide group of the cephamycins [J].Tetrahedron, 1980, 36 (19): 2735-2740. 被引量:1
  • 9[6]Yamanaka H, Chiba T, Kawabata K, et al. Studies on β-lactam antibiotics synthesis and biological activity of new orally active cephalosporin, cefixime (FK027) [J]. JAntibiot, 1985,38(12): 1738-1751. 被引量:1
  • 10[7]Aburaki S, Narito Y, Okumura J, et al. Cephalosporin intermediates[P]. US: 4659812, 1987-04-21. (CA 1987, 107:96507) 被引量:1

共引文献58

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部